Global Octreotide Market
市场规模（十亿美元）
CAGR :
% 
 Forecast Period |
2023 –2030 |
 Market Size (Base Year) |
USD 3.00 Billion |
 Market Size (Forecast Year) |
USD 3.80 Billion |
 CAGR |
% |
| Major Markets Players |
|
>全球奥曲肽市场，按类型（醋酸奥曲肽、奥曲肽、氯化奥曲肽、盐酸奥曲肽、铟 In-111；奥曲肽）、形式（注射剂、粉末、微球）、适应症（腹泻、肢端肥大症、其他）、最终用户（医院、家庭护理、专科诊所、其他）、分销渠道（医院药房、网上药房、零售药房）划分 - 行业趋势和预测到 2030 年。
奥曲肽市场分析和规模
肢端肥大症和癌症等疾病的发病率不断上升，预计将激增对奥曲肽药物的需求，进而有望推动市场增长。被诊断为癌症的人数不断增加，大大增加了对奥曲肽药物的需求。预计 2021 年，美国将出现 1,898,160 例新发癌症病例和 608,570 例癌症死亡病例。仿制药的日益普及可能会影响品牌药物的消费。
Data Bridge Market Research 分析了 2023-2030 年预测期内奥曲肽市场的增长率。在上述预测期内，奥曲肽市场的预期复合年增长率趋于 3% 左右。2022 年市场价值为 30 亿美元，到 2030 年将增长至 38 亿美元。除了市场价值、增长率、细分市场、地理覆盖范围、市场参与者和市场情景等市场洞察外，Data Bridge Market Research 团队策划的市场报告还包括深入的专家分析、患者流行病学、管道分析、定价分析和监管框架。
奥曲肽市场范围和细分
|
报告指标 |
细节 |
|
预测期 |
2023 至 2030 年 |
|
基准年 |
2022 |
|
历史岁月 |
2021（可定制为 2015 - 2020） |
|
定量单位 |
收入（单位：十亿美元）、销量（单位：台）、定价（美元） |
|
涵盖的领域 |
类型（醋酸奥曲肽、奥曲肽、氯化奥曲肽、盐酸奥曲肽、铟-111；奥曲肽）、剂型（注射剂、粉剂、微球）、适应症（腹泻、肢端肥大症、其他）、最终用户（兽医医院、专科诊所、其他）、分销渠道（医院药房、零售药房、其他）、分销渠道（医院药房、网上药房、零售药房） |
|
覆盖国家 |
北美洲的美国、加拿大和墨西哥、德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、欧洲其他地区、中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、亚太地区 (APAC) 的其他地区、沙特阿拉伯、阿联酋、南非、埃及、以色列、中东和非洲 (MEA) 的其他地区、巴西、阿根廷和南美洲其他地区 |
|
涵盖的市场参与者 |
Novartis AG (Switzerland), Sun Pharmaceutical Industries Ltd. (India), China National Pharmaceutical Group Corporation (China), Sihuan Pharmaceutical Holdings Group Ltd (China), Shanghai Soho-Yiming Pharmaceuticals Co.,Ltd. (China) |
|
Market Opportunities |
|
Market Definition
Octreotide is a type of hormone drug which is used to treat some types of cancer. It is sold under the brand name Sandostatin among others and is a long-acting injection used to control acromegaly and carcinoid tumours in people. This class of medications is also known as octapeptides. This medication is also used to treat extreme watery diarrhoea and sudden reddening of the face. This medication works by hindering the production of natural substances hormones.
Octreotide Market Dynamics
Drivers
- Increasing Pipeline of Drugs
The robust pipeline of drugs in clinical trials is expected to boost the market growth. For instance, in 2016, Mario Negri Institute for pharmacological research completed phase 2 clinical trials of its Octreotide LAR along with tolvaptan drug used for the treatment of autosomal dominant polycystic kidney disease. Octreotide sponsored by Radbound University is in phase 3 clinical trials from 2016. This drug is under clinical trial for the treatment of vascular malformations, angiodysplasia, gastrointestinal hemorrhage, and anemia with octreotide. Injection Octreotide, which is sponsored by PVS memorial hospital is in phase 4 clinical trials since 2016. This injection is precisely used for treatment of pancreatic fistula and complications of pancreatoduodenectomy among patients with soft pancreas. Moreover, CAM2029 is being tested, that is currently in phase 2, for acromegaly and neuroendocrine tumors by Camurus AB in collaboration with Novartis AG. Octreotide chloride is the active ingredient for this product.
Opportunities
- Growing Drug Launches
A growing number of launches relating to novel Octreotide acetate products by major market players is anticipated to drive market growth. For instance, in 2013, Sagent Pharmaceuticals, which is a U.S.-based biopharmaceutical company, launched its new drug Octreotide acetate, a samatostatin analog. This drug is used to decrease blood levels of IGF-I and growth hormone in acromegaly patients who do not sufficiently respond to or who cannot be treated by surgery, irradiation and bromocriptine mesylate.
- Increasing Rates of Cancer
The global demand for octreotide is boosted by increasing number of people under the diagnosis of cancer. In 2012, there were projected 14.1 million cases of cancer .It is expected that by 2035, the number of people surviving from cancer will be about 24 million. These estimate shows that the demand for treatment drugs such as octreotide will grow. It is estimated that about 2200 children die every day because of severe diarrhea, more than Aids, malaria and measles combined.
Restraints/Challenges
- High Cost of Treatment
The enormous expenditure associated with the treatment of octreotide impede the market growth. The treatment becomes quite unaffordable in middle-income countries, thus, in a way limiting the market growth.
This octreotide market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the octreotide market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth
Global Octreotide Market Scope
The octreotide market is segmented on the basis of type, form, indications, distribution channel and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Type
- octreotide acetate
- octreotide
- octreotide chloride
- octreotide hydrochloride
- indium In-111; octreotide
Form
- Injection
- Powder
- Microspheres
Indications
- Diarrhoea
- Acromegaly
- Others
End User
- Hospitals
- Homecare
- Specialty Clinics
- Others
Distribution Channel
- Hospital Pharmacy
- Online Pharmacy
- Retail Pharmacy
Octreotide Market Regional Analysis/Insights
The octreotide market is analyzed and market size insights and trends are provided by type, form, indications, distribution channel and end-user as referenced above.
The major countries covered in the octreotide market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
Asia-Pacific has been witnessing a positive growth for octreotide market throughout the forecasted period due to increased new research and developments on octreotide market.
North America dominates the market due to the presence of key manufacturers of the product is high and, increasing research and development activities.
报告的国家部分还提供了影响市场当前和未来趋势的各个市场影响因素和国内市场监管变化。此外，在提供国家数据预测分析时，还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的激烈竞争或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。
竞争格局和全球奥曲肽市场份额分析
奥曲肽市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对奥曲肽市场的关注有关。
奥曲肽市场的主要参与者包括：
- 诺华公司（瑞士）
- 太阳制药工业有限公司 (印度)
- 中国医药集团公司 (中国)
- 四环医药控股集团有限公司 (中国)
- 上海苏豪益明药业有限公司（中国）
- JB Pharma（印度）
- Samarth Life Sciences Pvt. Ltd.（印度）
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
研究方法
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
可定制
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
